NewsBite

Street Talk

Crescent dumps Australian Clinical Lab stake; E&P on ticket

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Crescent Capital Partners’ time on Australian Clinical Labs’ register is done and dusted.

Australian Clinical Labs is the No.3 player in the pathology market. Louie Douvis

Loading...
Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones. Email Sarah at sarah.thompson@afr.com
Kanika Sood is a journalist based in Sydney who writes for the Street Talk column. Email Kanika at kanika.sood@afr.com.au
Emma Rapaport is a co-editor of the Street Talk column. Prior to that, she was a markets reporter at The Australian Financial Review. Connect with Emma on Twitter. Email Emma at emma.rapaport@afr.com

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Read More

Original URL: https://www.afr.com/street-talk/crescent-dumps-australian-clinical-lab-stake-e-and-p-on-ticket-20240911-p5k9ux